- Home
- CNTA vs RPD Comparison
CNTA vs RPD Comparison
Compare CNTA & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- RPD
- Stock Information
- Founded
- CNTA 2020
- RPD 2000
- Country
- CNTA United Kingdom
- RPD United States
- Employees
- CNTA N/A
- RPD N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- RPD Computer Software: Prepackaged Software
- Sector
- CNTA Health Care
- RPD Technology
- Exchange
- CNTA Nasdaq
- RPD Nasdaq
- Market Cap
- CNTA 1.8B
- RPD 1.5B
- IPO Year
- CNTA 2021
- RPD 2015
- Fundamental
- Price
- CNTA $12.30
- RPD $25.14
- Analyst Decision
- CNTA Strong Buy
- RPD Buy
- Analyst Count
- CNTA 10
- RPD 21
- Target Price
- CNTA $26.11
- RPD $38.89
- AVG Volume (30 Days)
- CNTA 617.5K
- RPD 848.7K
- Earning Date
- CNTA 05-20-2025
- RPD 05-12-2025
- Dividend Yield
- CNTA N/A
- RPD N/A
- EPS Growth
- CNTA N/A
- RPD N/A
- EPS
- CNTA N/A
- RPD 0.40
- Revenue
- CNTA N/A
- RPD $844,007,000.00
- Revenue This Year
- CNTA N/A
- RPD $3.70
- Revenue Next Year
- CNTA N/A
- RPD $4.87
- P/E Ratio
- CNTA N/A
- RPD $63.08
- Revenue Growth
- CNTA N/A
- RPD 8.53
- 52 Week Low
- CNTA $7.75
- RPD $21.61
- 52 Week High
- CNTA $19.09
- RPD $44.48
- Technical
- Relative Strength Index (RSI)
- CNTA 40.97
- RPD 53.17
- Support Level
- CNTA $11.88
- RPD $23.50
- Resistance Level
- CNTA $14.39
- RPD $24.63
- Average True Range (ATR)
- CNTA 0.79
- RPD 0.83
- MACD
- CNTA -0.00
- RPD 0.42
- Stochastic Oscillator
- CNTA 18.68
- RPD 81.30
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.